A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma
NCT00319683
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
INDUSTRY
Sponsor class
Stopped
Lack of funds
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
ADH300004
Sponsor
Adherex Technologies, Inc.